Trials / Completed
CompletedNCT03620487
Detection of Dengue Virus in Plasma of Patients in Nepal
Pathogen Detection and Host Response in Plasma of Patients With Dengue and Dengue Fever Like Illnesses in Nepal.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 643 (actual)
- Sponsor
- Karius, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To test whether Karius Infectious Disease Diagnostic Sequencing assay can detect Dengue Virus in plasma from suspected cases of Dengue or Dengue Fever like-illnesses from samples collected as part of a hospital-based multi-site study conducted in Nepal.
Detailed description
Blood samples will be obtained from consented subjects as part of a hospital-based multi-site study conducted in Nepal and will be shipped to Karius, Redwood City, CA. The investigators will test whether the Karius test can detect Dengue Virus in plasma from those suspected cases and measure the performance of the Karius test against standard tests (PCR, ELISA test and neutralization assays) used to determine a final diagnosis of Dengue Fever.
Conditions
Timeline
- Start date
- 2016-10-26
- Primary completion
- 2020-03-31
- Completion
- 2020-07-31
- First posted
- 2018-08-08
- Last updated
- 2023-02-14
Locations
1 site across 1 country: Nepal
Source: ClinicalTrials.gov record NCT03620487. Inclusion in this directory is not an endorsement.